+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

Proto-oncogene Protein C-bcl-2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto-oncogene Protein C-bcl-2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Brutons Tyrosine Kinase (BTK) Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Hematopoietic Progenitor Kinase 1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Hematopoietic Progenitor Kinase 1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Innovation Insights: B-cell Depletion - Product Thumbnail Image

Innovation Insights: B-cell Depletion

  • Report
  • December 2024
  • 55 Pages
  • Global
From
BRAFV600 Mutation (B-Raf Proto-oncogene, Serine/threonine Kinase) Inhibiotors - Pipeline Insight, 2025 - Product Thumbnail Image

BRAFV600 Mutation (B-Raf Proto-oncogene, Serine/threonine Kinase) Inhibiotors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Epithelioma Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Thumbnail Image

Epithelioma Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • February 2025
  • 130 Pages
  • Global
From
ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • July 2023
  • 407 Pages
  • Global
From
Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035

  • Report
  • May 2023
  • 391 Pages
  • Global
From
Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates) - Product Thumbnail Image

Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)

  • Report
  • February 2022
  • 84 Pages
  • Global
From
Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035 - Product Thumbnail Image

Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035

  • Report
  • October 2021
  • 145 Pages
  • Global
From
Fc Fusion Therapeutics Market by Target Indications, Type of Fusion Molecule, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Fc Fusion Therapeutics Market by Target Indications, Type of Fusion Molecule, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 150 Pages
  • Global
From
Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030 - Product Thumbnail Image

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

  • Report
  • February 2020
  • 360 Pages
  • Global
From
Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways - Product Thumbnail Image

Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways

  • Report
  • August 2019
  • 488 Pages
  • Global
From
Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review - Product Thumbnail Image

Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review

  • Report
  • July 2025
  • Global
From
Brazil Cancer Drugs Clinical Trials Insight 2024 - Product Thumbnail Image

Brazil Cancer Drugs Clinical Trials Insight 2024

  • Report
  • August 2024
  • 660 Pages
  • Brazil
From
China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

  • Report
  • September 2022
  • 300 Pages
  • China
From
Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028 - Product Thumbnail Image

Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028

  • Report
  • June 2022
  • 1500 Pages
  • Global
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more